• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

178.14 +1.32 (+0.75%)
Streaming Delayed Price Updated: 11:54 AM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Zoetis Announces First Quarter 2022 Results
May 05, 2022
From Zoetis Inc.
Via Business Wire
Earnings Scheduled For May 5, 2022
May 05, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. 
Via Benzinga
CNBC's Final Trades: Zoetis, VanEck Gold Miners ETF, Paramount Global And This Energy Stock
May 03, 2022
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said Zoetis Inc (NYSE: ZTS) is “the largest provider of vaccines and medicines for pets and live 
Via Benzinga
Zoetis: Q4 Earnings Insights
February 15, 2022
  Zoetis (NYSE:ZTS) reported its Q4 earnings results on Tuesday, February 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why This Petcare Stock Is Hitting Record Highs
December 29, 2021
The pet care sector was already growing rapidly, but the coronavirus pandemic has only accelerated its growth. 
Via Talk Markets
Why Stephanie Link Is Watching Starbucks And This Stock Down Nearly 30% YTD
May 02, 2022
Hightower Advisors' Stephanie Link believes we are still in the midst of a bull market. Accordingly, she has identified a couple of stocks well off their highs that she would like to buy on any further... 
Via Benzinga
Zoetis Foundation Announces First Round of 2022 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Wellness
April 12, 2022
From Zoetis Inc.
Via Business Wire
Blue-Chip Pharma Stock Among Best to Own This Quarter
April 06, 2022
With the second quarter currently underway, traders have the chance to revisit their portfolios and make any necessary adjustments. 
Via Talk Markets
Zoetis to Host Webcast and Conference Call on First Quarter 2022 Financial Results
March 31, 2022
From Zoetis Inc.
Via Business Wire
The New 'Return On Character' ETF Doesn't Include Musk Or Zuckerberg: Who Made The Cut?
March 25, 2022
A new active ETF launched this week with a unique spin on how it picks the companies to include in the fund. What Happened: ROC I... 
Via Benzinga
3 Beaten-Down Growth Stocks With More Than 50% Upside Potential
February 25, 2022
The key to picking growth stocks right now is to look for companies whose earnings momentum and growth can withstand any market conditions. 
Via InvestorPlace
Zoetis to Participate in the Bank of America Securities 2022 Animal Health Summit
February 22, 2022
From Zoetis Inc.
Via Business Wire
Zoetis's Return On Capital Employed Insights
February 16, 2022
Pulled from Benzinga Pro data, Zoetis (NYSE:ZTS) posted Q4 earnings of $413.00 million, an increase from Q3 of 25.18%. Sales dropped to $1.97 billion, a 1.16% decrease between quarters. 
Via Benzinga
4 Top Stock Trades for Wednesday: NVDA, SPCE, ABNB, ZTS
February 15, 2022
Nvidia, Virgin Galactic, Airbnb and Zoetis were our top stock trades for Wednesday. Here's how the charts are setting up right now. 
Via InvestorPlace
Zoetis Tops Quarterly Forecasts As Spot And Fluffy Contribute To Sales Growth
February 15, 2022
Companion animal sales continued their lead with livestock sales falling again. 
Via Investor's Business Daily
Zoetis Q4 Sales Cushioned By Higher Companion Animal Product Sales, Issues FY22 Outlook
February 15, 2022
Zoetis Inc (NYSE: ZTS) has reported Q4 FY21 revenue of $2 b 
Via Benzinga
Zoetis Q4 Sales Cushioned By Higher Companion Animal Product Sales, Issues FY22 Outlook
February 15, 2022
Zoetis Inc. has reported Q4 FY21 revenue of $2 billion, an increase of 9% Y/Y, beating the consensus of $1.93 billion. 
Via Talk Markets
Zoetis Reports Fourth Quarter and Full Year 2021 Results
February 15, 2022
From Zoetis Inc.
Via Business Wire
Earnings Scheduled For February 15, 2022
February 15, 2022
Companies Reporting Before The Bell • FirstService (NASDAQ:FSV) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.07 billion. 
Via Benzinga
Earnings Outlook For Zoetis
February 14, 2022
Zoetis (NYSE:ZTS) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that Zoetis will report an... 
Via Benzinga
Zoetis Declares Second Quarter 2022 Dividend
February 08, 2022
From Zoetis Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
January 20, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
7 of the Top-Rated Pharmaceutical Stocks for Q1
January 18, 2022
As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks. 
Via InvestorPlace
Zoetis's Ex-Dividend Date Is Tuesday, Here's What You Need To Know
January 14, 2022
Tuesday marks the last chance for investors to receive the next dividend payout from Zoetis. What's Happening (NYSE: 
Via Benzinga
FDA Approves Zoetis' Solensia To Control Osteoarthritis Pain In Cats
January 14, 2022
The FDA has approved Zoetis Inc's (NYSE: ZTS) Solensia (frunevetmab injection) to control the pain of osteoarthritis (OA) in cats, helping improve their... 
Via Benzinga
Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats
January 13, 2022
From Zoetis Inc.
Via Business Wire
Zoetis Announces Expanded Commitments to Protect the Planet
January 06, 2022
From Zoetis Inc.
Via Business Wire
4 Top Stock Trades for Wednesday: AVGO, AMD, ARKK, ZTS
January 04, 2022
Advanced Micro Devices, Broadcom, the ARKK ETF and Zoetis were our top stock trades for Wednesday. Now, let's take a look at the charts. 
Via InvestorPlace
Zoetis to Participate in the 40th Annual J.P. Morgan Healthcare Conference
December 23, 2021
From Zoetis Inc.
Via Business Wire
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2021 Financial Results
December 23, 2021
From Zoetis Inc.
Via Business Wire
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap